SEC Form 4 · accession 0001567619-18-005458
Emergent BioSolutions Inc. · EBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kathryn C Zoon
Director
Period of report
Nov 7, 2018
Accepted (ET)
Nov 8, 2018 · 6:49 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Nov 7, 2018 | S | 2,371 | $69.4804 | D | 20,514 | D | |
| Common StockF3 | Nov 7, 2018 | S | 1,871 | $70.0789 | D | 18,643 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Zoon.
- F2The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.90 to $70.14, inclusive.
- F3The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.05 to $70.18, inclusive.